about
Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null alleleThe minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinMatching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation.A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.Predicting alloreactivity in transplantation.The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.Identification of minor histocompatibility antigens based on the 1000 Genomes ProjectFunctional antigen matching in corneal transplantation: matching for the HLA-A, -B and -DRB1 antigens (FANCY) - study protocolPhenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populationsRisk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.Children with celiac disease and high tTGA are genetically and phenotypically differentComplete donor chimerism is a prerequisite for the effect of Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) on acute graft-versus-host disease.A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation during a Subsequent Successful Pregnancy.Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.Computational Approaches to Facilitate Epitope-Based HLA Matching in Solid Organ TransplantationIndirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome.Minor histocompatibility antigens: past, present, and future.Immunogenetic factors in the selection of cord blood units for transplantation: current search strategies and future perspectives.A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.Completion of HLA protein sequences by automated homology-based nearest-neighbor extrapolation of HLA database sequences.The PROCARE consortium: toward an improved allocation strategy for kidney allografts.Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitro.Molecular characterization and T-cell-stimulatory capacity of Mycobacterium leprae antigen T5.Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells.Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool.The presence of protective cytotoxic T lymphocytes does not correlate with shorter lifespans of productively infected cells in HIV-1 infection.Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.The novel HLA-B*44:02:27 allele, identified by sequencing-based typing of a candidate stem-cell donor.Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes.Differential effects of donor-specific HLA antibodies in living- versus deceased-donor transplantation.Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
P50
Q27654544-C37A1CFF-4BE1-4A97-8D3E-345D31BA10D6Q28187004-ED3A8431-E90B-4D3C-87BF-6F5DE8F73EB3Q33261330-127C3631-8212-4B54-AE6D-AAC7F0E181D1Q33267303-FDC1EB8D-8EB4-40B8-99D2-D50914CC9A29Q33608371-B6CE8C52-6505-4647-BA0C-8B1BFCAF5E95Q34121730-DBED55ED-3961-4236-BBFF-A4FBC528D6D5Q34648976-66F35ECC-AF29-4E0C-B0F0-CBE4DE3F9BE4Q34940174-6921F57E-F5A4-4A36-98EE-F5AF02D7D04FQ35865440-B9828ADD-406D-4A24-AE67-6048B5AADE80Q36797747-19B19C5A-5F24-469C-9A55-B7EDE49112E7Q37285295-8C0ADDA5-C78F-4B80-8739-9C7B6CDDA9DDQ37337095-DEF40020-7199-40F1-9CEE-C76567163361Q37475111-06F4CF09-57DE-49A0-AFF8-8FABDA14D32CQ37488382-8C0DFC19-D3ED-4906-A37D-B27AD507075CQ37555836-476FC50C-4CDD-4D6A-A31B-AC9172AC4B40Q37670811-ABC5570C-4B2C-4CAF-8FE4-7D46EF2B1E4CQ38214655-9C1C7DB5-FD42-479E-9A32-A1533230FA7AQ38254976-5B8F0164-28AC-440F-9CC9-A80ABBB2826FQ38377504-F81B0F77-0FC1-479B-A44B-14E2DB26CC7EQ38674730-7C14BEE6-53CF-4E5A-B98E-3490F7E43A17Q38726059-9FE9CC07-D441-4757-A468-7632BDC38732Q38883763-D8A265A4-D42D-47EC-8C17-A4226710C163Q39122863-CCE687B0-562A-4DAB-9135-529BF3A92735Q39677445-AC26F00E-1CDC-4DE2-9D1E-EA9FA8E6C2A7Q39823652-BE9AD58C-0BAE-4594-9D17-2BB051A320EAQ40001935-044981F5-9EF5-4B50-B04D-D70C93705171Q40328875-5A2B2C8F-102F-462C-87E6-541875107889Q40380942-6B30E4C1-2767-4A8A-BD11-7EBF3C78618FQ40416244-AB8437C3-7AD4-4B2C-B8FB-69902C8BCB86Q40594727-B3C8529B-4951-46B8-AB2D-635C38B36807Q40845236-11EA0050-82FA-462A-8214-6D0E1E811844Q41121054-A4547ED1-9BAE-4352-B000-A53FB78ADB56Q41368439-905D4458-2D31-406A-8546-8B41E7B987A5Q45066753-A5CF3353-6FFE-478D-AE6D-408EE7EE41D2Q45349920-F953146F-7AC2-4A69-86B9-9E2B036B810FQ45737549-6D0FF193-0FF1-4C50-9D50-B31E9A07BC48Q47842670-13EC6DD2-50EC-48B1-94DF-D3C7A25BE35FQ49718575-7C4C84EC-8F50-4B37-B73C-0A9083CFA2E5Q49719376-F885C8A7-8AD0-4AF0-8D2A-912DB86857ECQ51071716-D55005FB-F158-4682-853E-8D77DEEFE38D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Spierings
@ast
Eric Spierings
@en
Eric Spierings
@es
Eric Spierings
@nl
Eric Spierings
@sl
type
label
Eric Spierings
@ast
Eric Spierings
@en
Eric Spierings
@es
Eric Spierings
@nl
Eric Spierings
@sl
prefLabel
Eric Spierings
@ast
Eric Spierings
@en
Eric Spierings
@es
Eric Spierings
@nl
Eric Spierings
@sl
P106
P1153
7006778873
P2798
P31
P496
0000-0001-9441-1019